QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.050534v1 306/2/563    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Damjanoska, K. J. Articles by Muma, N. A. Search for Related Content PubMed PubMed Citation Articles by Damjanoska, K. J. Articles by Muma, N. A.

NEUROPHARMACOLOGY

Chronic Fluoxetine Differentially Affects 5-Hydroxytryptamine_2A Receptor Signaling in Frontal Cortex, Oxytocin- and Corticotropin-Releasing Factor-Containing Neurons in Rat Paraventricular Nucleus

Center for Serotonin Disorders Research and Department of Pharmacology and Experimental Therapeutics, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois

Differential adaptive changes in serotonin_2A [5-hydroxytryptamine (5-HT)_2A] receptor signaling during treatment may be one mechanism involved in the latency of therapeutic improvement with antidepressants, such as fluoxetine. We examined the effects of fluoxetine (2, 3, 7, 21, or 42 days) on hypothalamic 5-HT_2A receptor signaling. The hormone responses to an injection of the 5-HT_2A receptor agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane HCl (DOI) were used as an index of hypothalamic 5-HT_2A receptor function. Treatment with fluoxetine for 21 or 42 days produced diminished adrenocorticotropic hormone (ACTH) and oxytocin (but not corticosterone) responses to DOI injections (2.5 mg/kg i.p.; 15 min postinjection). Regulators of G protein signaling 4 and G_q protein levels in the hypothalamic paraventricular nucleus were not altered during fluoxetine treatment. Because previous studies indicate that treatment with fluoxetine for 21 days resulted in increased hormone responses to DOI when measured at 30 min after injection, we examined the effect of fluoxetine (21 days) on DOI-induced increase hormone levels at 15, 30, and 60 min after DOI injection. Fluoxetine decreased the oxytocin response at 15 but not at 30 min post-DOI injection, and potentiated the ACTH and corticosterone responses at 30 min post-DOI injection. For comparison, we examined the effect of fluoxetine on 5-HT_2A receptor-mediated increase in phospholipase C (PLC) activity in the frontal cortex. 5-HT-stimulated, but not guanosine 5'-O-(3-thio)triphosphate-stimulated PLC activity was increased after 21 days of fluoxetine-treatment. Overall, these results indicate that chronic fluoxetine treatment can potentiate 5-HT_2A receptor signaling in frontal cortex but differentially alters 5-HT_2A receptor signaling in oxytocin-containing neurons and corticotropin-releasing factor-containing neurons in the paraventricular nucleus.

Address correspondence to: Dr. Nancy A. Muma, Department of Pharmacology, Loyola University Chicago, Stritch School of Medicine, 2160 South First Ave., Maywood, IL 60153. E-mail: nmuma{at}lumc.edu

This article has been cited by other articles:

				J. A. Mennigen, C. J. Martyniuk, K. Crump, H. Xiong, E. Zhao, J. Popesku, H. Anisman, A. R. Cossins, X. Xia, and V. L. Trudeau Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus) Physiol Genomics, November 12, 2008; 35(3): 273 - 282. [Abstract] [Full Text] [PDF]

				D. Meyer Selective Serotonin Reuptake Inhibitors and Their Effects on Relationship Satisfaction The Family Journal, October 1, 2007; 15(4): 392 - 397. [Abstract] [PDF]

				J. Shi, K. J. Damjanoska, R. K. Singh, G. A. Carrasco, F. Garcia, A. J. Grippo, M. Landry, N. R. Sullivan, G. Battaglia, and N. A. Muma Agonist Induced-Phosphorylation of G{alpha}11 Protein Reduces Coupling to 5-HT2A Receptors J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 248 - 256. [Abstract] [Full Text] [PDF]

				I. Morecroft, L. Loughlin, M. Nilsen, J. Colston, Y. Dempsie, J. Sheward, A. Harmar, and M. R. MacLean Functional Interactions between 5-Hydroxytryptamine Receptors and the Serotonin Transporter in Pulmonary Arteries J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 539 - 548. [Abstract] [Full Text] [PDF]

				Y. Zhang, T. S. Gray, D. N. D'Souza, G. A. Carrasco, K. J. Damjanoska, B. Dudas, F. Garcia, G. M. Zainelli, N. R. Sullivan Hanley, G. Battaglia, et al. Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 59 - 66. [Abstract] [Full Text] [PDF]